The present invention concerns s-ship promoter compositions and methods using the promoter. It includes polynucleotides, vectors, host cells, and transgenic animal including an s-ship promoter controlling the expression of a heterologous nucleic acid. Methods of the invention concern methods of expressing a heterologous nucleic acid is a tissue-specific, developmental-specific, or temporally controlled manner. Other methods includes screening methods and therapeutic methods.